J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ_老虎社区_美港股上老虎

J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ

Reuters2021-07-29

July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.

Production of J&J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&J's vaccines.

J&J, Emergent and the FDA did not immediately respond to Reuters requests for comment.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

AnaiAnai
·2021-07-29
good. at least more vaccines are available. More people will be vaccinated earlier and can go back to normalcy sooner.
回复
1
举报
June陈
·2021-07-29
....
回复
1
举报
Bptan1973
·2021-07-29
Good news
回复
4
举报
收起
- Bptan1973:
  Done, thank you bro
  2021-07-29
  回复
  举报
- 在於我們是:
  Hi please like and comment [Smile]
  2021-07-29
  回复
  举报
MoneyCum
·2021-07-29
Yeah
回复
6
举报
BWMoxx
·2021-07-29
Ohhhh
回复
6
举报
收起
- TeslaLegend:
  Nice
  2021-07-29
  回复
  举报
- jenx:
  wow
  2021-07-29
  回复
  举报
geraldzhang
·2021-07-29
more people need to get vaccinated before the world can open up
回复
8
举报
收起
- JeromeLim:
  nice
  2021-07-29
  回复
  举报
- Fatboy79:
  U are brainwashed big time
  2021-07-29
  回复
  举报
RICHSG2021
·2021-07-29
Single shot vaccine will be a big boost
回复
10
举报
收起
- AppleMango:
  But need boost dose later on!
  2021-07-29
  回复
  举报
Hehehaha0088
·2021-07-29
😮😮
回复
6
举报
jtan81
·2021-07-29
Price going up
回复
5
举报
收起
- Rexgan:
  [Strong]
  2021-07-29
  回复
  举报
alvinherexD
·2021-07-29
Gg
回复
4
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2155413972?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-07-29 13:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2155413972","market":"us","top_or_hot":-1,"title":"J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ","media":"Reuters","content":"<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ\n</h2>\n\n<h4 class=\"meta\">\n\n2021-07-29 13:46 北京时间&nbsp;&nbsp;&nbsp;<strong>Reuters</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug ...</p>\n\n<a href=\"None\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EBS","symbol_name":"Emergent Biosolutions","start_time":0,"source_url":null,"article_id":"2155413972","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2155413972","pubTimestamp":1627537612,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EBS":"Emergent Biosolutions","JNJ":"强生"},"translate_title":"J&J承包商计划在巴尔的摩工厂恢复新冠肺炎疫苗生产-WSJ","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EBS":0.9,"JNJ":0.9},"content_text":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.\nProduction of J&J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&J's vaccines.\nJ&J, Emergent and the FDA did not immediately respond to Reuters requests for comment.","kind":"highlight","is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":808007639,"gmtCreate":1627540583321,"gmtModify":1633763971291,"author":{"id":"3583884958321017","authorId":"3583884958321017","name":"AnaiAnai","avatar":"https://static.tigerbbs.com/8b0d0d8e20a4082ac0bc6a98756546ec","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3583884958321017","authorIdStr":"3583884958321017"},"htmlText":"good. at least more vaccines are available. More people will be vaccinated earlier and can go back to normalcy sooner.","listText":"good. at least more vaccines are available. More people will be vaccinated earlier and can go back to normalcy sooner.","text":"good. at least more vaccines are available. More people will be vaccinated earlier and can go back to normalcy sooner.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/808007639","repostId":2155413972,"repostType":4,"repost":{"id":"2155413972","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627537612,"share":"https://www.laohu8.com/m/news/2155413972?lang=&edition=full","pubTime":"2021-07-29 13:46","market":"us","language":"en","title":"J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2155413972","media":"Reuters","summary":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 ","content":"<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-29 13:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","EBS":"Emergent Biosolutions"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155413972","content_text":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.\nProduction of J&J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&J's vaccines.\nJ&J, Emergent and the FDA did not immediately respond to Reuters requests for comment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":808006940,"gmtCreate":1627540256080,"gmtModify":1633763973449,"author":{"id":"4087997917943030","authorId":"4087997917943030","name":"June陈","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4087997917943030","authorIdStr":"4087997917943030"},"htmlText":"....","listText":"....","text":"....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/808006940","repostId":2155413972,"repostType":4,"repost":{"id":"2155413972","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627537612,"share":"https://www.laohu8.com/m/news/2155413972?lang=&edition=full","pubTime":"2021-07-29 13:46","market":"us","language":"en","title":"J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2155413972","media":"Reuters","summary":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 ","content":"<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-29 13:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","EBS":"Emergent Biosolutions"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155413972","content_text":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.\nProduction of J&J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&J's vaccines.\nJ&J, Emergent and the FDA did not immediately respond to Reuters requests for comment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":808000158,"gmtCreate":1627539752574,"gmtModify":1631889349472,"author":{"id":"3564648657215594","authorId":"3564648657215594","name":"Bptan1973","avatar":"https://static.tigerbbs.com/3bc9afb30415a151838a752cc38621fc","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3564648657215594","authorIdStr":"3564648657215594"},"htmlText":"Good news&nbsp;","listText":"Good news&nbsp;","text":"Good news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/808000158","repostId":2155413972,"repostType":4,"repost":{"id":"2155413972","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627537612,"share":"https://www.laohu8.com/m/news/2155413972?lang=&edition=full","pubTime":"2021-07-29 13:46","market":"us","language":"en","title":"J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2155413972","media":"Reuters","summary":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 ","content":"<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-29 13:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","EBS":"Emergent Biosolutions"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155413972","content_text":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.\nProduction of J&J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&J's vaccines.\nJ&J, Emergent and the FDA did not immediately respond to Reuters requests for comment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5366499,"gmtCreate":1627539922797,"gmtModify":1631889349481,"authorId":3564648657215594,"author":{"id":3564648657215594,"idStr":"3564648657215594","authorId":3564648657215594,"name":"Bptan1973","avatar":"https://static.tigerbbs.com/3bc9afb30415a151838a752cc38621fc","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":808000158,"type":1,"supId":5366491,"prevId":0,"content":"Done, thank you bro","text":"Done, thank you bro","html":"Done, thank you bro"},{"id":5366491,"gmtCreate":1627539847561,"gmtModify":1631889349471,"authorId":3580638845558081,"author":{"id":3580638845558081,"idStr":"3580638845558081","authorId":3580638845558081,"name":"在於我們是","avatar":"https://static.tigerbbs.com/400933d41d715fa2dc89a42f82e63f64","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":808000158,"type":1,"supId":0,"prevId":0,"content":"Hi please like and comment [Smile]","text":"Hi please like and comment [Smile]","html":"Hi please like and comment [Smile]"}],"langContent":"EN"},{"id":801777879,"gmtCreate":1627539632992,"gmtModify":1631889362619,"author":{"id":"3575437443107611","authorId":"3575437443107611","name":"MoneyCum","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3575437443107611","authorIdStr":"3575437443107611"},"htmlText":"Yeah","listText":"Yeah","text":"Yeah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/801777879","repostId":2155413972,"repostType":4,"repost":{"id":"2155413972","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627537612,"share":"https://www.laohu8.com/m/news/2155413972?lang=&edition=full","pubTime":"2021-07-29 13:46","market":"us","language":"en","title":"J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2155413972","media":"Reuters","summary":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 ","content":"<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-29 13:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","EBS":"Emergent Biosolutions"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155413972","content_text":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.\nProduction of J&J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&J's vaccines.\nJ&J, Emergent and the FDA did not immediately respond to Reuters requests for comment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":801746231,"gmtCreate":1627538268423,"gmtModify":1633763987068,"author":{"id":"4088487325195880","authorId":"4088487325195880","name":"BWMoxx","avatar":"https://static.tigerbbs.com/694294fee8427f7a37139676fc8accaa","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4088487325195880","authorIdStr":"4088487325195880"},"htmlText":"Ohhhh","listText":"Ohhhh","text":"Ohhhh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/801746231","repostId":2155413972,"repostType":4,"repost":{"id":"2155413972","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627537612,"share":"https://www.laohu8.com/m/news/2155413972?lang=&edition=full","pubTime":"2021-07-29 13:46","market":"us","language":"en","title":"J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2155413972","media":"Reuters","summary":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 ","content":"<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-29 13:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","EBS":"Emergent Biosolutions"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155413972","content_text":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.\nProduction of J&J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&J's vaccines.\nJ&J, Emergent and the FDA did not immediately respond to Reuters requests for comment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5366376,"gmtCreate":1627538609805,"gmtModify":1635165153262,"authorId":3572489627147183,"author":{"id":3572489627147183,"idStr":"3572489627147183","authorId":3572489627147183,"name":"TeslaLegend","avatar":"https://static.tigerbbs.com/180ad6f06095bcbf2b6594d26c494752","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":801746231,"type":1,"supId":0,"prevId":0,"content":"Nice","text":"Nice","html":"Nice"},{"id":5366386,"gmtCreate":1627538699561,"gmtModify":1635165152497,"authorId":3587023056098177,"author":{"id":3587023056098177,"idStr":"3587023056098177","authorId":3587023056098177,"name":"jenx","avatar":"https://static.tigerbbs.com/422c2ebfc14a61dc15dd098a40cd6a5e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":801746231,"type":1,"supId":0,"prevId":0,"content":"wow","text":"wow","html":"wow"}],"langContent":"EN"},{"id":801748995,"gmtCreate":1627538105917,"gmtModify":1633763988304,"author":{"id":"3586925174439094","authorId":"3586925174439094","name":"geraldzhang","avatar":"https://static.tigerbbs.com/a6ee4e3782e4a4ac9a9642f37d663fbc","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586925174439094","authorIdStr":"3586925174439094"},"htmlText":"more people need to get vaccinated before the world can open up","listText":"more people need to get vaccinated before the world can open up","text":"more people need to get vaccinated before the world can open up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/801748995","repostId":2155413972,"repostType":4,"repost":{"id":"2155413972","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627537612,"share":"https://www.laohu8.com/m/news/2155413972?lang=&edition=full","pubTime":"2021-07-29 13:46","market":"us","language":"en","title":"J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2155413972","media":"Reuters","summary":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 ","content":"<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-29 13:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","EBS":"Emergent Biosolutions"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155413972","content_text":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.\nProduction of J&J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&J's vaccines.\nJ&J, Emergent and the FDA did not immediately respond to Reuters requests for comment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5366469,"gmtCreate":1627539521398,"gmtModify":1631894108124,"authorId":3587032744649801,"author":{"id":3587032744649801,"idStr":"3587032744649801","authorId":3587032744649801,"name":"JeromeLim","avatar":"https://static.tigerbbs.com/c658561fa4bd29c8ff80d04c9a0f0d14","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":801748995,"type":1,"supId":0,"prevId":0,"content":"nice","text":"nice","html":"nice"},{"id":5366397,"gmtCreate":1627538809013,"gmtModify":1631894108116,"authorId":3560390730639874,"author":{"id":3560390730639874,"idStr":"3560390730639874","authorId":3560390730639874,"name":"Fatboy79","avatar":"https://static.tigerbbs.com/f550c98b42b2fd97e2989fbf50af5b9b","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":801748995,"type":1,"supId":0,"prevId":0,"content":"U are brainwashed big time","text":"U are brainwashed big time","html":"U are brainwashed big time"}],"langContent":"EN"},{"id":801749298,"gmtCreate":1627537937514,"gmtModify":1633763990477,"author":{"id":"4089003739432960","authorId":"4089003739432960","name":"RICHSG2021","avatar":"https://static.tigerbbs.com/bbd874826d817a4e6c7f5dbfa5c3e3a0","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"4089003739432960","authorIdStr":"4089003739432960"},"htmlText":"Single shot vaccine will be a big boost","listText":"Single shot vaccine will be a big boost","text":"Single shot vaccine will be a big boost","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/801749298","repostId":2155413972,"repostType":4,"repost":{"id":"2155413972","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627537612,"share":"https://www.laohu8.com/m/news/2155413972?lang=&edition=full","pubTime":"2021-07-29 13:46","market":"us","language":"en","title":"J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2155413972","media":"Reuters","summary":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 ","content":"<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-29 13:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","EBS":"Emergent Biosolutions"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155413972","content_text":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.\nProduction of J&J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&J's vaccines.\nJ&J, Emergent and the FDA did not immediately respond to Reuters requests for comment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5366432,"gmtCreate":1627539151755,"gmtModify":1635165148509,"authorId":3567141277226150,"author":{"id":3567141277226150,"idStr":"3567141277226150","authorId":3567141277226150,"name":"AppleMango","avatar":"https://static.tigerbbs.com/68d3e430c230d4cfd4e97044c56f2b6d","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":801749298,"type":1,"supId":5366335,"prevId":0,"content":"But need boost dose later on!","text":"But need boost dose later on!","html":"But need boost dose later on!"}],"langContent":"EN"},{"id":801740619,"gmtCreate":1627537814531,"gmtModify":1633763991448,"author":{"id":"4089495674612980","authorId":"4089495674612980","name":"Hehehaha0088","avatar":"https://static.tigerbbs.com/e1f5d328fb2801a4b62fb90386325a31","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4089495674612980","authorIdStr":"4089495674612980"},"htmlText":"😮😮","listText":"😮😮","text":"😮😮","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/801740619","repostId":2155413972,"repostType":4,"repost":{"id":"2155413972","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627537612,"share":"https://www.laohu8.com/m/news/2155413972?lang=&edition=full","pubTime":"2021-07-29 13:46","market":"us","language":"en","title":"J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2155413972","media":"Reuters","summary":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 ","content":"<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-29 13:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","EBS":"Emergent Biosolutions"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155413972","content_text":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.\nProduction of J&J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&J's vaccines.\nJ&J, Emergent and the FDA did not immediately respond to Reuters requests for comment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":801757152,"gmtCreate":1627537634476,"gmtModify":1633763992361,"author":{"id":"4088115866953670","authorId":"4088115866953670","name":"jtan81","avatar":"https://static.tigerbbs.com/ab77bef51ae360a3fff1aeb6955101a7","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4088115866953670","authorIdStr":"4088115866953670"},"htmlText":"Price going up","listText":"Price going up","text":"Price going up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/801757152","repostId":2155413972,"repostType":4,"repost":{"id":"2155413972","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627537612,"share":"https://www.laohu8.com/m/news/2155413972?lang=&edition=full","pubTime":"2021-07-29 13:46","market":"us","language":"en","title":"J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2155413972","media":"Reuters","summary":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 ","content":"<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-29 13:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","EBS":"Emergent Biosolutions"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155413972","content_text":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.\nProduction of J&J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&J's vaccines.\nJ&J, Emergent and the FDA did not immediately respond to Reuters requests for comment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5366421,"gmtCreate":1627539048472,"gmtModify":1635165149400,"authorId":3573536145611474,"author":{"id":3573536145611474,"idStr":"3573536145611474","authorId":3573536145611474,"name":"Rexgan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":801757152,"type":1,"supId":0,"prevId":0,"content":"[Strong]","text":"[Strong]","html":"[Strong]"}],"langContent":"EN"},{"id":801754769,"gmtCreate":1627537613651,"gmtModify":1633763992603,"author":{"id":"3563936204183553","authorId":"3563936204183553","name":"alvinherexD","avatar":"https://static.tigerbbs.com/581a2f621e388bf7f33b560eee3cfcc8","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3563936204183553","authorIdStr":"3563936204183553"},"htmlText":"Gg","listText":"Gg","text":"Gg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/801754769","repostId":2155413972,"repostType":4,"repost":{"id":"2155413972","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627537612,"share":"https://www.laohu8.com/m/news/2155413972?lang=&edition=full","pubTime":"2021-07-29 13:46","market":"us","language":"en","title":"J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2155413972","media":"Reuters","summary":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 ","content":"<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-29 13:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 28 (Reuters) - Johnson &amp; Johnson contractor <a href=\"https://laohu8.com/S/EBS\">Emergent Biosolutions</a> Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.</p>\n<p>Production of J&amp;J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&amp;J's vaccines.</p>\n<p>J&amp;J, Emergent and the FDA did not immediately respond to Reuters requests for comment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","EBS":"Emergent Biosolutions"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155413972","content_text":"July 28 (Reuters) - Johnson & Johnson contractor Emergent Biosolutions Inc plans to resume COVID-19 vaccine production at its Baltimore plant after getting approval from the U.S. Food and Drug Administration (FDA), the Wall Street Journal reported late on Wednesday, citing a statement from the company and a FDA letter.\nProduction of J&J's COVID-19 vaccine at the Baltimore site was halted by U.S. authorities in April following a discovery that ingredients from AstraZeneca's COVID-19 vaccine, also being produced at the plant at that time, contaminated a batch of J&J's vaccines.\nJ&J, Emergent and the FDA did not immediately respond to Reuters requests for comment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":46,"commentSize":10,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false}}